Circulating apelin, IL22RA2 and VEGF in pre-capillary pulmonary hypertension

Author:

Csósza Györgyi1,Szűcs Gergő1,Rozgonyi Zsolt2,Csoma Balázs1,Losonczy György1,Müller Veronika1,Karlócai Kristóf1,Lázár Zsófia1ORCID

Affiliation:

1. Department of Pulmonology, Semmelweis University, Budapest, Hungary

2. Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary

Abstract

AbstractCytokines can modulate vascular remodelling and the adaptation of the right ventricle in pre-capillary pulmonary hypertension (PH). However, detailed data on the circulating levels of cytokines in patients are limited. We measured blood cytokine concentration in 39 treatment-naïve patients (pulmonary arterial hypertension: N = 16, chronic thromboembolic PH: N = 15, PH due to lung disease: N = 8) and 12 control subjects using enzyme-linked immunoassays. Apelin concentration >1,261 ng/mL identified patients with PH (66% sensitivity and 82% specificity), and in patients it was related to systolic pulmonary arterial pressure (PAP) (r = 0.33, P = 0.04), right atrial pressure (r = 0.38, P = 0.02), cardiac index (r = −0.34, P = 0.04), and right ventricular stroke work index (r = −0.47, P = 0.003). IL22RA2 concentration correlated with mean PAP (r = −0.32, P = 0.04) and serum N-terminal pro B-type natriuretic peptide level (r = −0.42, P = 0.01). VEGF concentration increased in patients upon clinical improvement (N = 16, P = 0.02). Circulating apelin is a novel biomarker of pre-capillary PH. Apelin and IL22RA2 levels are related to right ventricular function upon diagnosis of PH.

Funder

Hungarian Respiratory Foundation to Dr. Györgyi Csósza

Publisher

Akademiai Kiado Zrt.

Subject

Physiology (medical)

Reference42 articles.

1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Humbert M,2022

2. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives;Humbert M,2019

3. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology;Vonk-Noordegraaf A,2013

4. Novel biomarkers for pulmonary arterial hypertension;Anwar A,2016

5. Growth factors in pulmonary arterial hypertension: focus on preserving right ventricular function;Csosza G,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3